Inhibition of Notch Signaling in Combination with Paclitaxel Reduces Platinum-Resistant Ovarian Tumor Growth

Introduction: Ovarian cancer (OvCa) is the most lethal gynecologic malignancy in the United States because of chemoresistant recurrent disease. Our objective was to investigate the efficacy of inhibiting the Notch pathway with a γ-secretase inhibitor (GSI) in an OvCa patient-derived xenograft model...

Descripción completa

Detalles Bibliográficos
Autores principales: Groeneweg, Jolijn W., DiGloria, Celeste M., Yuan, Jing, Richardson, William S., Growdon, Whitfield B., Sathyanarayanan, Sriram, Foster, Rosemary, Rueda, Bo R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083224/
https://www.ncbi.nlm.nih.gov/pubmed/25072022
http://dx.doi.org/10.3389/fonc.2014.00171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083224/
https://www.ncbi.nlm.nih.gov/pubmed/25072022
http://dx.doi.org/10.3389/fonc.2014.00171

Ejemplares similares